14
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Treatment of Drug Intoxication: A Review of Some Scientific Principles

Pages 249-265 | Published online: 25 Sep 2008

References

  • Done A. K. Drugs for the Treatment of Poisoning. Drugs of Choice, W. Modell. Mosby, Chicago 1968
  • Done A. K. Pharmacologic Principles in the Treatment of Poisoning. Pharmacol. Physicians 1969; 3(7)
  • Arena J. M. Poisoning: Toxicology, Symptoms, Treatment. Thomas, Spring-field, IIL 1969
  • Dreisbach R. H. Handbook of Poisoning: Diagnosis and Treatment. Lange Medical, Los Altos, Calif. 1969
  • Gleason M. N., Gosselin R. E., Hodge H. C., Smith R. E. Clinical Toxicology of Commercial Products. William & Wilkins, Baltimore, Md. 1969
  • Gosselin R. E., Smith R. P. ldquo;Trends in the Therapy of Acute Poisonings”. Clin. Pharmacol. Therap. 1966; 7: 279–299
  • Strickler J. C. ldquo;Forced Diuresis in the Management of Barbiturate Intoxication”. Clin. Pharmacol. Therap. 1965; 6: 693–699
  • Bloomer H. A. A Critical Evaluation of Diuresis in the Treatment of Barbiturate Intoxication. J. Lab. Clin. Med. 1966; 67: 898–905
  • Arena J. M. ldquo;Treatment of Poisoning”. Mod. Treatment 1967; 4: 591–740
  • Done A. K. ldquo;Treatment of Salicylate Poisoning: Review of Personal and Published Experiences”. Clin. Toxicol. 1968; 1: 451–467
  • Maher J. F., Schreiner G. E. ldquo;The Dialysis of Poisons and Drugs”. Trans. Am. Soc. Artificial Internal Organs 1969; 15: 459–477
  • Rushton D. G. Salicylates. Churchill, London 1963
  • Goldstein M. I., Robertson W. O., Harlor A. D. Evaluating Methods for Emptying the Stomach. Bull. Natl. Clearinghouse Poison Control Centers March-April, 1963
  • Arnold F. J., Hodges J. B., Barta R. A. ldquo;Evaluation of the Efficacy of Lavage and Induced Emesis in the Treatment of Salicylate Poisoning”. Peditrics 1959; 23: 286–301
  • Levy G., Jaffe S. J. ldquo;The Study of Salicylate Pharmacokinetics in Intoxicated Infants and Children”. Clin. Toxicol. 1968; 1: 409–424
  • Holt L. E., Holz P. H. ldquo;The Black Bottle; a Consideration of the Role of Charcoal in the Treatment of Poisoning in Children”. J. Pediat. 1963; 63: 306–314
  • Picchioni A. L., Chin L., Verhulst H. L. A Preliminary Investigation Involving the Relative Efficacy of Activated Charcoal and the “Universal Antidote,”. Bull Natl. Clearinghouse Poison Control Centers Jan.-Feb., 1965
  • Anderson A. H. ldquo;Experimental Studies on the Pharmacology of Activated Charcoal; Adsorption Power of Charcoal in Aqueous Solutions”. Acta. Pharmacol. Toxicol. 1946; 2: 69–78
  • Levy G., Tsuchiya T. Effect of Activated Charcoal on Aspirin Absorption in Man. Pharmacologists 1969; 11: 292
  • Kutt H., Wolk M., Scherman R., McDowell F. ldquo;Insufficient p-Hydroxylation as a Cause of Diphenylhydantion Toxicity”. Neurology 1964; 14: 547–548
  • Levy G. ldquo;Pharmacokinetics of Salicylate Elimination in Man”. J. Pharm. Sci. 1965; 54: 959–967
  • Burns J. J., Rose R. K., Chenkin T., Goldman A., Shultert A., Brodie B. B. The Physiological Disposition of Phenylbutazone in Man and a Method for Its Estimation in Biological Material. J. Pharmacol. Exptl. Therap. 1953; 109: 346–357
  • Levy G., Matsuzawa T. ldquo;Pharmacokinetics of Salicylamide Elimination in Man”. J. Pharmacol. Exptl. Therap. 1967; 156: 285–293
  • O'Reilly R. A., Aggeler P. M., Leung L. S. ldquo;Studies on the Coumarin Anticogulant Drugs: A Comparison of the Pharmacodynamics of Dicumarol and Warfarin in Man”. Thromb. Diath. Haemorrhag. 1964; 11: 1–22
  • Dayton P. G., Cucinell S. A., Weiss M., Perel J. M. ldquo;Dose Dependence of Drug Plasma Level Decline in Dogs”. J. Pharmacol. Exptl. Therap. 1967; 158: 305–316
  • Gerber N., Arnold K. ldquo;Studies on the Metabolism of Diphenylhydantoin in Mice”. J. Pharmacol. Exptl. Therap. 1969; 167: 77–90
  • Weiner L. M., Mudge G. H. ldquo;Renal Tubular Mechanisms for Excretion of Organic Acids and Bases”. Am. J. Med. 1964; 36: 743–762
  • Setter J. G., Freeman R. B., Maher J. F., Schreiner G. E. ldquo;Factors Influencing the Dialysis of Barbituates”. Trans. Am. Soc. Internal. Organs 1964; 10: 340–344
  • Mark L. C. ldquo;Metabolism of Barbiturates in Man”. Clin. Pharmacol. Therap. 1963; 4: 504–530
  • Milne M. D., Scribner B. H., Crawford M. A. ldquo;Non-ionic Diffusion and Exaction of Weak Acids and Bases”. Am. J. Med. 1958; 24: 709–729
  • Krahl M. E. The Effect of Ionic Strength and Temperature on the Apparent Dissociation Constants of Thirty Substituted Barbituric Acids. J. Phys. Chem. 1940; 44: 449–463
  • Waddell W. J., Butler T. C. ldquo;The Distribution and Excretion of Phenobarbital”. J. Clin. Invest. 1957; 36: 1217–1226
  • Goldbaum L. R., Smith P. K. ldquo;The Interaction of Barbiturates with Serum Albumin and Its Possible Relation to Their Disposition and Pharmacologcal Actions”. J. Pharmacol. Exptl. Therap. 1954; 111: 197–209
  • Nahas G. G., Gjessing J., Giroux J. J., Verosky M., Mark L. C. ldquo;The Passage of THAM across the Peritoneum during Dialysis”. Clin. Pharmacol. Therap. 1965; 6: 560–567
  • Etteldorf J. N., Dobbins W. T., Summitt R. L., Rainwater W. T., Fischer R. L. ldquo;Intermittent Pentoneal Dialysis using Five Per cent Albumin in the Treatment of Salicylate Intoxication in Children”. J. Pediat. 1961; 58: 226–236
  • Berman L., Vogelsang P. ldquo;Removal Rates for Barbiturates Using Two Types of Peritoneal Dialysis”. New Engl. J. Med. 1964; 270: 77–80
  • Myschetsky A., Lassen N. A. Urea Induced, Osmotic Diuresis and Alkalinization of Urine in Acute Barbiturate Intoxication. J. Am. Med. Assoc. 1963; 185: 936–942
  • Penzotti S. C., Mattocks A. M. ldquo;Acceleration of Peritoneal Dialysis by Surface Active Agents”. J. Pharm. Sci. 1968; 57: 1192–1195
  • Yatzidis H., Oreopoulos D., Triantaphyllidis D., Voudiclari S., Tsaparas N., Gavras C., Stavroulaki A. ldquo;Treatment of Severe Barbiturate Poisoning”. Lancet 1965; 2: 216–217
  • Dunea G., Kolff W. J. ldquo;Clinical Experience with the Yatzidis Charcoal Artifical Kidney”. Trans. Am. Soc. Artifical Internal Organs 1965; 11: 178–182
  • DeMyttenaere M. H., Maher J. F., Schreiner G. E. Hemoperfusion through a Charcoal Column for Glutethimide Poisoning. Trans. Am. Soc. Artifical. Organs 1967; 13: 190–198
  • Dedrick R. L., Vantoch P., Gombos E. A., Moore R. ldquo;Kinetics of Activated Carbon Kidney”. Trans. Am. Soc. Artifical. Internal Organs 1967; 13: 236–242
  • Shinaberger J. H., Martinez F. G., Ogland K. ldquo;Lipid Dialysate for Removal of Fat Soluble Compounds by Hemodialysis: Treatment of Glutethimide intoxication”. Intern. Congr. Nephrol. 1966; 2: 271–275
  • Ginn H. E., Anderson K. E., Mercier R. K., Stevens T. W., Matter B. J. ldquo;Camphor Intoxication Treated by Lipid Dialysis”. J. Am. Med. Assoc. 1968; 203: 164–165
  • Shinaberger J. H., Shear L., Clayton L. E., Barry K. G., Knowlton M., Goldbaum L. R. ldquo;Dialysis for Intoxication with Lipid Soluble Drugs: Enhancement of Glutethimide Extraction with Lipid Dialysate”. Trans. Am. Soc. Artificial Internal Organs 1965; 11: 173–177

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.